The gene regulatory landscape of healthy and failed repair proximal tubule subpopulations in kidney disease
肾脏疾病中健康和修复失败的近端小管亚群的基因调控景观
基本信息
- 批准号:10599152
- 负责人:
- 金额:$ 5.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Chronic kidney disease (CKD) has an immense burden on healthcare, with a prevalence of 37 million in the
American population. Untreated CKD leads to fibrosis and declining renal function until a patient requires life-
sustaining renal replacement therapy, so there is a critical need for treatment options to halt or reverse the
progression of disease. My lab has characterized a pro-inflammatory cell type, originating from the failed repair
of injured proximal tubule (FR-PT) cells, that correlates with failed recovery from acute kidney injury (AKI) and
subsequent transition to CKD. Single cell RNA and ATAC sequencing of human adult kidney samples has
provided evidence for this cell state’s presence in kidneys that have not experienced AKI. As such the FR-PT
cell could represent a convergence point for acute and chronic renal injury through which progressive
inflammatory and fibrotic signals are perpetuated, leading to CKD progression. A treatment that inhibits or
reverses transition to a failed repair state could ameliorate CKD outcomes by reducing the FR-PT cell
population responsible for continued pro-inflammatory and pro-fibrotic signaling. Since FR-PT cells appear to
be a distinct population from healthy proximal tubule (PT) cells, gene regulatory mechanisms may be an
important contributing factor to the formation of FR-PT cells. This project will reveal the gene regulatory
networks and regulatory elements underpinning development of the FR-PT cell population through analysis of
a single cell multiomic dataset generated by integrating single cell RNA-seq and ATAC-seq profiles of adult
human kidney, specifically focusing on characterizing transcriptional and epigenetic differences between
healthy PT and FR-PT cells. This dataset will be used to train a parametric gene regulatory network model for
PT cells to identify candidate cis- and trans-regulatory elements involved in the transition between healthy and
failed repair PT states. This will be followed by experimental validation of the identified regulatory elements to
confirm their predicted role. This proposal aims to identify therapeutic candidates targeting FR-PT cells as a
driver of CKD progression, addressing an outstanding need for better CKD therapies. Completion of this
project will also help me achieve my training goals to expand my scientific knowledge, learn to identify and
study translatable research questions, and gain experience with bioinformatics and single cell techniques. Dr.
Benjamin Humphreys is a model physician-scientist for these goals, and his laboratory is an optimal
environment for this project and my training goals, because of his research group’s single cell expertise and
the lab’s excellent training and collaborative atmosphere. Successful completion of this project will contribute a
better understanding of CKD and possible treatment strategies and will prepare me to pursue a career as an
independent physician-scientist.
慢性肾脏疾病(CKD)在医疗保健上遭受了巨大烧伤,患病率为3700万
美国人口。未经处理的CKD导致纤维化和肾功能下降,直到患者需要生命为止
维持肾脏替代疗法,因此需要治疗选择以停止或逆转
疾病的进展。我的实验室表征了促炎细胞类型,源自失败的维修
受伤的近端管(FR-PT)细胞,与急性肾损伤(AKI)恢复失败相关,并且
随后过渡到CKD。人类成人肾脏样品的单细胞RNA和ATAC测序具有
提供了这种细胞状态在没有经历过AKI的肾脏中存在的证据。这样fr-pt
细胞可能代表急性和慢性肾损伤的收敛点
炎症和纤维化信号已永久存在,导致CKD进展。抑制或
逆转过渡到失败的维修状态可以通过减少FR-PT细胞来改善CKD结果
负责持续促炎和促纤维化信号传导的人群。由于Fr-Pt-PT细胞似乎
与健康的近端小管(PT)细胞是一个不同的人群,基因调节机制可能是一种
引起FR-PT细胞形成的重要促成因素。该项目将揭示基因调节性
通过分析,网络和监管元素为FR-PT细胞种群开发而言
通过整合成人的单细胞RNA-seq和ATAC-Seq曲线而生成的单细胞多组分数据集
人类肾脏,特别着重于表征转录和表观遗传学差异
健康的PT和FR-PT细胞。该数据集将用于训练一个参数基因调节网络模型
PT细胞以鉴定候选者顺式和反式调节元素,涉及健康和
维修状态失败。随后将对已确定的调节元素进行实验验证
确认他们的预测作用。该建议旨在确定针对FR-PT细胞的治疗候选者
CKD进展的驱动程序,满足了对更好CKD疗法的杰出需求。完成此操作
项目还将帮助我实现培训目标,以扩大我的科学知识,学习识别和
研究可翻译的研究问题,并获得生物信息学和单细胞技术的经验。博士
本杰明·汉弗莱斯(Benjamin Humphreys)是这些目标的典范物理科学家,他的实验室是最佳的
该项目的环境和我的培训目标,因为他的研究小组的单元专业知识和
该实验室的出色培训和协作气氛。该项目的成功完成将有助于
更好地了解CKD和可能的治疗策略,并将为我做好准备从事职业
独立的物理科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Research Project 1: A Multidimensional Molecular Atlas of Healthy and Diseased Human Pediatric Kidney
研究项目 1:健康和患病人类儿童肾脏的多维分子图谱
- 批准号:1053027010530270
- 财政年份:2022
- 资助金额:$ 5.16万$ 5.16万
- 项目类别:
Research Project 1: A Multidimensional Molecular Atlas of Healthy and Diseased Human Pediatric Kidney
研究项目 1:健康和患病人类儿童肾脏的多维分子图谱
- 批准号:1070796010707960
- 财政年份:2022
- 资助金额:$ 5.16万$ 5.16万
- 项目类别:
Single Cell Chromatin Profiling in Kidney Tissue
肾脏组织中的单细胞染色质分析
- 批准号:1037342610373426
- 财政年份:2021
- 资助金额:$ 5.16万$ 5.16万
- 项目类别:
Single cell multiomic and spatial atlas of acute and chronic kidney injury
急慢性肾损伤的单细胞多组学和空间图谱
- 批准号:1070344410703444
- 财政年份:2017
- 资助金额:$ 5.16万$ 5.16万
- 项目类别:
Tissue Chip Data to the Microphysiology Systems Database (MPS-Db) Supplement to A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
微生理学系统数据库 (MPS-Db) 的组织芯片数据补充用于肾脏疾病建模和药效测试的微生理学系统
- 批准号:1043532810435328
- 财政年份:2017
- 资助金额:$ 5.16万$ 5.16万
- 项目类别: